This patent is a owned by the embryonic stem cell powerhouse, ES International from Singapore. The patent covers a method of administration of embryonic stem cells that have been differentiated into neuron-like cells. The invention contains one independent claim, specifically covering: "a method of administration of stem cell derived neural progenitors" but the neural progenitors are obtained by in vitro culture in serum free medium supplemented with B27 and growth factors comprising EGF and bFGF . The neural progenitors that are administered are known by expression of markers of primitive neuroectoderm and neural stem cells.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.